This investigational once-weekly therapy is designed to activate three (i.e. GLP-3) natural metabolic pathways involved in appetite, energy balance, blood-sugar regulation, and how the body uses stored energy. Clinical studies suggest it may support substantial weight reduction while improving several markers associated with metabolic health.
By targeting multiple aspects of metabolic health, this emerging therapy may eventually offer a powerful tool for improving quality of life and supporting a longer, healthier healthspan.
Three distinct pathways:
Appetite and fullness support through GLP-1
Blood-sugar and metabolic support through GIP
Energy-use and fat-metabolism support through glucagon-receptor activity
Research use only. Individual results may vary.
This investigational once-weekly therapy is designed to activate three (i.e. GLP-3) natural metabolic pathways involved in appetite, energy balance, blood-sugar regulation, and how the body uses stored energy. Clinical studies suggest it may support substantial weight reduction while improving several markers associated with metabolic health.
By targeting multiple aspects of metabolic health, this emerging therapy may eventually offer a powerful tool for improving quality of life and supporting a longer, healthier healthspan.
Three distinct pathways:
Appetite and fullness support through GLP-1
Blood-sugar and metabolic support through GIP
Energy-use and fat-metabolism support through glucagon-receptor activity
Research use only. Individual results may vary.